Skip to main content
Clinical Trials/NL-OMON47850
NL-OMON47850
Not Yet Recruiting
N/A

The evaluation of the cerebellar symptoms in patients with opsoclonus myoclonus syndrome diagnosed and treated at the Sophia*s Children*s hospital - Evaluation of long term sequelae and treatment outcomes in OMS

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
40
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients with OMS, diagnosed and treated at the Sophia Children\*s Hospital will be included. OMS is defined as the presence of \*3 of the following symptoms: \[1] opsoclonus, \[2] myoclonus and/or ataxia, \[3] behavioural change and/or sleep disturbance and \[4] neuroblastoma.
  • Age\-matched children with pilocytic astrocytoma, diagnosed and treated at the Sophia Children\*s Hospital will be included.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • \- Insufficient command of the Dutch language (spoken and/or written)
  • \- Age above 12 years
  • Children with pilocytic astrocytoma will be excluded from participation, when they were treated with radiotherapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials